bioRxivCancer BiologyPreprint
Inhibitor of the spindle assembly checkpoint surpasses apoptosis sensitizer in synergy with taxanes
Teng-Long Han, Zhi-Xin Jiang, Yun-Tian Li, Deng-Shan Wu, Jun Ji, Hu Lin, Bin Hu, Hang Sha
Abstract
The antitumor effect of taxanes have been attributed to their ability to induce mitotic arrest through activation of the spindle assembly checkpoint. Cell death following prolonged mitotic arrest is mediated by the intrinsic apoptosis pathway. Thus, apoptosis sensitizers which inhibit antiapoptotic Bcl-2 family proteins has been shown to enhance taxanes-induced cell death. By contrast, spindle checkpoint disruption facilitates mitotic slippage and is thought to promote taxanes resistance. Notably, other modes of cell death also contribute to treatment outcomes. Here we show that inhibition of the spindle checkpoint suppresses taxanes induced apoptosis but increases terminal growth arrest of tumor cells with features of cellular senescence. By using clonogenic assay which measures the net result of multiple forms of cell death and is more reflective of therapeutic response, our finding suggests apoptosis is not a major determinant of antitumor efficacy of taxanes, whereas spindle checkpoint inhibitor displays a long-term advantage over apoptosis sensitizer in blocking colony outgrowth of tumor cells when combined with different microtubule toxins, therefore represents a superior therapeutic strategy.\n\nSIGNIFICANCEApoptosis has long been regarded as the primary mechanism of anti-cancer efficacy of taxanes, while the role of the spindle assembly checkpoint (SAC) in treatment response to taxanes has been controversial. Either apoptosis sensitizer or inhibitor of SAC has been reported to synergize with taxanes. While inhibitor of antiapoptotic proteins potentiates taxanes induced apoptosis, inhibitor of SAC suppresses apoptosis by facilitating mitotic slippage, that is why it is implicated in taxanes resistance. By demonstrating that apoptotic rates are not associate with long-term treatment response, not only do we find that inhibitor of SAC displays a long-term advantage over apoptosis sensitizer in combination with taxanes, but we also resolve the dispute around the role of SAC in cellular response to taxanes.
- organism: human
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Suppression of Docetaxel induced apoptosis in Survivin-depleted cells due to failure of sustained mitotic block
- CDC20 determines the sensitivity to spindle assembly checkpoint (SAC) inhibitors
S. Zheng, L. Raz, … U. Ben-David·bioRxiv·Dec 21, 2023
- A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in pancreatic cancer cells
P. Mondal, G. Alyateem, … M. M. Gottesman·bioRxiv·Feb 15, 2024
- The mTORC1/S6K/PDCD4/eIF4A axis determines outcome of mitosis.
Mohamed Moustafa-Kamal, Thomas J. Kucharski, … Jose G. Teodoro·Cell ReportsPeer-reviewed·Oct 1, 2020
- Paclitaxel-induced mitotic arrest results in a convergence of apoptotic dependencies that can be safely exploited by BCL-XL degradation to overcome cancer chemoresistance
Xingping Qin, Adam G. Presser, … Kristopher A. Sarosiek·bioRxiv·Jun 24, 2025
- YY2/BUB3 axis-mediated SAC hyperactivity determines tumor cell fate through chromosomal instability